FTFatih Turkmen

Fatih Turkmen

*This is an algorithmically generated author record based on publicly available information.

Fatih Turkmen has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cellular Effects of a Topical Hemostatic Agent Used for Acute Bleeding Control: An in Vitro Study in MCF-7 and HEK-293 Cells

    by Selçuk Eren Çanakçı, Fatih Türkmen, Ferhat Şirinyıldız, Simge Ünay, Aslı Çanakçı, Kenan Ahmet Türkdoğan

    This exploratory in vitro study characterized 24 h responses to the topical hemostatic formulation Blood Stoper (TE’SIR) in MCF-7 and HEK-293 cells. Relative MTT reduction was assessed over 0.5–75% (v/v); qualitative scratch-gap observations and 24 h stained-cell aggregate counts were obtained in MCF-7 cells at 0.5%, 1%, and 7.5%, and supernatant malondialdehyde (MDA) and catalase readouts were obtained in both lines. In MCF-7 cells, the reported relative MTT signal declined from 72.61% at 0.5% to 15.23% at 7.5%; corresponding HEK-293 values were 114.30% and 35.44%. Images suggested impaired monolayer gap restoration, and fewer stained-cell aggregates were observed at higher exposures. Supernatant MDA and catalase readouts also varied across conditions. Inconsistencies in replication reporting, an unresolved MTT handling step, possible assay interference, and uncharacterized formulation pH, osmolality, and vehicle limit attribution of these patterns to biological effects. The results are descriptive and do not establish measured cell-survival fractions, oxidative injury mechanisms, tumor selectivity, or clinical biocompatibility. Independent validation in wound-relevant cells with formulation-matched controls is required.

  • Open Access

    Multimodal Pain Management in Emergency Medicine: A Narrative Review

    by Behcet AL, Fatih Turkmen

    Pain is one of the most common reasons for presentation to the emergency department, yet it remains frequently undertreated despite effective therapies. Emergency physicians must provide timely analgesia while accounting for diagnostic uncertainty, patient heterogeneity, and safety concerns, particularly related to opioid use.